Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required)

The National Institute of Allergy and Infectious Diseases (NIAID) is soliciting applications to create and operate the Infectious Diseases Clinical Trials Network (IDCTN). The network will consist of Clinical Trial Evaluation Units (CTEUs) that design and run clinical trials for emerging and chronic infectious diseases, and a Network Coordination Center (NCC) that provides administrative, operational, and scientific coordination. Awardees will receive a UM1 cooperative agreement (complex‑structure) and are expected to collaborate closely with NIH staff, contribute to protocol development, data management, regulatory compliance, and mentorship of early‑career investigators. Funding is anticipated at roughly $10 M (estimated) with a potential start date of March 2027. The effort is national in scope and open to a wide range of eligible entities (public, nonprofit, for‑profit, tribal, etc.) but excludes foreign organizations. • UM1 cooperative agreement for a national clinical‑trial network • Requires establishment of CTEUs and an NCC with NIH‑staff partnership • Focus on therapeutics, vaccines, biologics, diagnostics, and devices for infectious diseases • Eligible applicants: U.S. public, nonprofit, for‑profit, tribal, and educational institutions • Estimated total funding ≈ $10 M; award anticipated March 2027, project start March 2027 • Application deadline: 5 PM local time, November 10 2026 (open Oct 10 2026)